Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration

被引:144
|
作者
Pei, Jin-Jing [1 ]
Braak, Eva [2 ]
Braak, Heiko [2 ]
Grundke-Iqbal, Inge [3 ]
Iqbal, Khalid [3 ]
Winblad, Bengt [1 ]
Cowburn, Richard F. [1 ]
机构
[1] Karolinska Inst, Sect Geriatr Med, KFC, Novum,NEUROTEC, S-14186 Huddinge, Sweden
[2] Goethe Univ Frankfurt, Dept Anat, Frankfurt, Germany
[3] NYS Inst Basic Res Dev Disabil, Staten Isl, NY USA
基金
英国医学研究理事会;
关键词
Alzheimer's disease; JNK; p38; kinase; neurofibrillary tangles;
D O I
10.3233/JAD-2001-3107
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The principal protein component of paired helical filaments (PHFs) in Alzheimer disease is abnormally hyperphosphorylated tau (PHI-tau). The stress activated protein kinases JNK and p38 have been shown to phosphorylate tau at some sites only seen in PHI-tau. If JNK and p38 are involved in the abnormal hyperphosphorylation of tau, they should be activated in neurons undergoing neurofibrillary degeneration. In the present study, we determined the intracellular and regional distribution of the active forms of JNK and p38 kinase in entorhinal, hippocampal, and temporal cortices of brains staged for neurofibrillary changes according to Braak and Braak. Neurons with tangle-like inclusions positive for active forms of JNK and p38 kinase were found to appear first in the Pre-alpha layer of the entorhinal cortex, and then extend into other brain regions co-incident with the progressive sequence of neurofibrillary changes. The intraneuronal accumulation of active forms of JNK and p38 kinase apeared to precede the deposition of amyloid in the extracellular space. These data indicate that increased activation of the stress related kinases JNK and p38 occurs very early in the disease and might be involved in the intraneuronal protein phosphorylation/dephosphorylation imbalance that leads to neurofibrillary degeneration in Alzheimer disease.
引用
收藏
页码:41 / 48
页数:8
相关论文
共 50 条
  • [31] Neuronal MAP kinase p38α inhibits c-Jun N-terminal kinase to modulate anxiety-related behaviour
    Kristie Stefanoska
    Josefine Bertz
    Alexander M. Volkerling
    Julia van der Hoven
    Lars M. Ittner
    Arne Ittner
    Scientific Reports, 8
  • [32] Neuronal MAP kinase p38α inhibits c-Jun N-terminal kinase to modulate anxiety-related behaviour
    Stefanoska, Kristie
    Bertz, Josefine
    Volkerling, Alexander M.
    van der Hoven, Julia
    Ittner, Lars M.
    Ittner, Arne
    SCIENTIFIC REPORTS, 2018, 8
  • [33] Differential activation of p42-44 map kinase, p38 kinase and C-jun kinase by mast cell tryptase in human lung fibroblasts.
    Cairns, JA
    Walls, AF
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : S213 - S213
  • [34] Activation of p38 and c-Jun N-terminal kinase pathways and induction of apoptosis by chelerythrine do not require inhibition of protein kinase C
    Yu, R
    Mandlekar, S
    Tan, TH
    Kong, ANT
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (13) : 9612 - 9619
  • [35] Uroguanylin activates the extracellular-regulated kinase (ERK), c-jun NH2-terminal kinase (JNK), and p38 mitogen activated protein kinase in colon carcinoma cells via cGMP
    Carrithers, SL
    Pager, C
    Shah, R
    Greenberg, R
    FASEB JOURNAL, 2002, 16 (05): : A1162 - A1162
  • [36] The association of atypical protein kinase C with neurofibrillary pathology and granulovacuolar degeneration in Alzheimer's disease.
    Crary, JF
    Mirra, SS
    Shao, CY
    Braithwaite-Harte, L
    Tcherepanov, A
    Oxberry, W
    Sacktor, TC
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (05): : 550 - 550
  • [37] Modulation of the JNK and p38 pathways by cdk5 protein kinase in a transgenic mouse model of Alzheimer's disease
    Otth, C
    Mendoza-Naranjo, A
    Mujica, L
    Zambrano, A
    Concha, II
    Maccioni, RB
    NEUROREPORT, 2003, 14 (18) : 2403 - 2409
  • [38] Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor α
    Roulston, A
    Reinhard, C
    Amiri, P
    Williams, LT
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (17) : 10232 - 10239
  • [39] p38 mitogen activated protein kinase as a therapeutic target for Alzheimer's disease
    Dalrymple, SA
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2002, 19 (03) : 295 - 299
  • [40] p38 mitogen activated protein kinase as a therapeutic target for Alzheimer’s disease
    Stacie A. Dalrymple
    Journal of Molecular Neuroscience, 2002, 19 : 295 - 299